Editorial · 30 May 2025
Conference abstractPublished 26 Jun 2013
Identification of therapeutic targets in Leishmania donovani and Leishmania infantum
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The availability of genomic data of human parasites in public databases has made it possible to find drug targets in the pathogen. One such approach is genome subtraction where we try to find genes which are essential to the pathogen but not present in the host. Such gene products can be proved as potential targets in the parasites, with absolutely no host toxicity issues. The leishmaniases are a group of diseases caused by protozoan parasites of the genus Leishmania. The parasite is transmitted by bites from sand-flies infected with the parasite. Leishmaniasis presents in three main clinical forms: cutaneous, mucocutaneous and visceral, which are associated with a broad range of signs, symptoms and degrees of severity. The present study aims at identifying Potential Candidate Drug Targets In Leishmania Donovani and Leishmania Infantum through genome subtraction approach using Pairwise comparison. Protein sequences belonging to the parasite was derieved from NCBI genome and compared with human proteins. Non- homologous proteins were compared to essential genes present in Database of essential genes. Proteins which passed the screening parameters were considered essential to the parasite. These essential proteins were compared to Protein Data Bank, to obtain significant hits belonging to Leishmania Donovani and Leishmania Infantum. These hits were studied to obtain promising Targets in the parasite. Six potential targets were identified overall, namely topoisomerase, petridine reductase(PTR1) phosphoribosyl transferase, Trypanothione Reductase, OMP decarboxylase and Glyoxalase II.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Shivanjali Saxena”
- BylineArticles whose byline prints “Suhail Ahmad Khan”